Regencell Bioscience Holdings Ltd
RGC- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001829667
No open-market purchases or sales by Regencell Bioscience Holdings Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $8.56M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Regencell Bioscience Holdings Ltd changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 5 | 5 | 0 |
| Shares | 20.3K | 8.50K | −11.7K (−58.0%) |
| Value | $434.0K | $296.0K | −$138.0K (−31.8%) |
New holders (2)
Institutions that held Regencell Bioscience Holdings Ltd at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 6,816 | $238.0K | 0.00% |
| BlackRock Inc. | 238 | $8.00K | 0.00% |
Sold out (2)
Institutions that held Regencell Bioscience Holdings Ltd at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Qube Research & Technologies Ltd | 17,329 | $371.0K |
| Citigroup Inc | 2,240 | $48.0K |